Clinical trial for Bundibugyo Ebola begins in DR Congo as death toll hits 506
AI Summary
A clinical trial has commenced in the Democratic Republic of Congo to test experimental treatments for the Bundibugyo strain of Ebola amid an outbreak that has claimed 506 lives. The trial aims to improve care for patients infected with this rare but deadly virus.
Patients infected with the Bundibugyo strain of Ebola have begun receiving experimental treatments in a new clinical trial aimed at improving care for the rare but deadly virus, as the outbreak in the Democratic Republic of Congo (DRC) has claimed 506 lives. The post Clinical trial for Bundibugyo Ebola begins in DR Congo as death toll hits 506 appeared first on Nairametrics.